Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe
LP0160-1329
Approved small_molecule active
Quick answer
Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe for Moderate-to-severe plaque psoriasis and a body weight ≥120 kg. is a Approved program (small_molecule) at LEO Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEO Pharma A/S
- Indication
- Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
- Phase
- Approved
- Modality
- small_molecule
- Status
- active